Inotropes in preterm infants--evidence for and against

Area of Science:

• Neonatal physiology and pathophysiology
• Pediatric critical care medicine
• Hemodynamic monitoring in neonates

Background:

• Limited safe and reproducible biomarkers hinder optimal circulatory management in preterm infants.
• Understanding circulatory function is crucial for transitional care, sepsis, and necrotizing enterocolitis in neonates.

Purpose of the Study:

• To review the physiology and pathophysiology of circulatory function in preterm infants.
• To evaluate evidence for and against inotropic therapies in neonates.
• To provide recommendations for managing circulatory dysfunction in preterm infants.

Main Methods:

• Literature review of physiology, pathophysiology, and inotropic therapies.
• Analysis of evidence supporting and refuting common and novel inotropic agents.
• Development of a pragmatic management approach based on functional assessment.

Main Results:

• Blood pressure alone is a weak correlate of circulatory flow volume.
• A multi-faceted assessment of circulatory function is superior to isolated measures.
• Evidence for and against various inotropic therapies is critically evaluated.

Conclusions:

• A pragmatic, multi-system approach to circulatory assessment is recommended for preterm infants.
• Therapeutic interventions should be individualized based on desired functional outcomes.
• Frequent reassessment of response to interventions is essential for effective management.